Site Search | NIAMS

Displaying 141 - 158 of 158 results

Psoriasis

https://www.niams.nih.gov/health-topics/psoriasis

La psoriasis es una enfermedad de la piel que provoca que ciertas áreas de esta se enrojezcan y se vuelvan escamosas, pudiendo estar adoloridas, hinchadas o calientes. Aprenda más sobre los diferentes tipos de psoriasis y sus causas.

Hidradenitis supurativa

https://www.niams.nih.gov/health-topics/hidradenitis-suppurativa-hs

Aprenda sobre la hidradenitis supurativa, incluyendo cómo se diagnostica y se trata, y las medidas que puede tomar para vivir mejor con esta enfermedad.

Síndrome de Marfan

https://www.niams.nih.gov/health-topics/marfan-syndrome

¿Qué es el síndrome de Marfan? Es un trastorno que afecta el tejido conectivo que da sostén a muchas partes del cuerpo y a menudo es una enfermedad hereditaria.

Osteoporosis

https://www.niams.nih.gov/health-topics/osteoporosis

¿Qué es la osteoporosis? Es una enfermedad en la que los huesos se debilitan y tienen una mayor probabilidad de fracturarse. No hay síntomas hasta que se fractura un hueso.

Enfermedad de Sjögren

https://www.niams.nih.gov/health-topics/sjogrens-disease

¿Qué es la enfermedad de Sjögren? Es una enfermedad que afecta las glándulas que producen humedad. Por lo general, causa resequedad en la boca y los ojos.

Osteopetrosis

https://www.niams.nih.gov/health-topics/osteopetrosis

¿Qué es la osteopetrosis? La osteopetrosis es un trastorno poco frecuente que hace que los huesos crezcan de manera anormal y se vuelvan demasiado densos. Cuando esto sucede, los huesos pueden romperse fácilmente.

NIAMS Forum for Clinical Mentored K Awardees - December 2023

https://www.niams.nih.gov/newsroom/roundtable/niams-forum-clinical-mentored-k-awardees-december-2023

The K Forum brings together clinician-scientists with a NIAMS K08 or K23 award.

Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) Program

https://www.niams.nih.gov/grants-funding/niams-supported-research-programs/accelerating-medicines-partnership-amp

The Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program launched in 2021 with the goal of deepening our understanding of the cellular and molecular interactions that lead to inflammation and autoimmune diseases.

FY 2017 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2017/congressional-justification

February 2016 NOTE: The FY 2016 Enacted funding amounts cited throughout this chapter reflect the effects of OAR HIV/AIDS Transfers. Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section

NIAMS Forum for Clinical Mentored K Awardees - December 2020

https://www.niams.nih.gov/newsroom/roundtable/niams-forum-clinical-mentored-k-awardees-december-2020

NIAMS held its first K Forum in 2012. Based on the positive feedback received from participants, NIAMS convened subsequent meetings annually. T

Inflammation Resolution Roundtable - November 2021

https://www.niams.nih.gov/about/meetings-events/roundtables/inflammation-resolution-roundtable-november-2021

To improve understanding of the intrinsic mechanisms of inflammation resolution and of how dysregulated resolution may lead to chronic inflammation, the NIAMS held a roundtable on emerging opportunities in research on resolution of inflammation.

NIAMS Forum for Clinical Mentored K Awardees - December 2022

https://www.niams.nih.gov/newsroom/roundtable/niams-forum-clinical-mentored-k-awardees-december-2022

The K Forum brings together clinician-scientists with a NIAMS K08 or K23 award.

Cartilage Preservation and Restoration in Knee Osteoarthritis: Challenges, Gaps, and Opportunities Roundtable - September 2022

https://www.niams.nih.gov/about/meetings-events/roundtables/cartilage-preservation-and-restoration-knee-osteoarthritis

NIAMS organized a roundtable to engage stakeholders to discuss challenges, gaps, and opportunities regarding regenerative medicine approaches for cartilage preservation and restoration in knee OA and where and how NIAMS could play a role and move the field forward.

FY 2015 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2015/congressional-justification

March 2014 Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and title IV of the PHS Act with respect to arthritis and musculoskeletal and skin diseases, [$520,053,000]

Data and Safety Monitoring (DSM) Guidelines for NIAMS-Funded Clinical Research

https://www.niams.nih.gov/grants-funding/data-safety-monitoring/dsm-guidelines

Learn about the NIH and NIAMS policies and requirements for Data and Safety Monitoring (DSM), guidelines for creating a Data and Safety Monitoring Plan (DSMP), risk assessment and determination of monitoring type, types of monitoring bodies NIAMS may consider, and much more. Additional reporting requirements, such as the Institutional Review

FY 2020 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2020/congressional-justification

March 2019 FY 2020 Congressional Justification PDF version (1 MB) DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Top NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and

FY 2021 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2021/congressional-justification

FY 2021 Congressional Justification page (HTML and downloadable PDF)

FY 2019 Congressional Justification

https://www.niams.nih.gov/about/budget/fy2019/congressional-justification

April 2018 FY 2019 Congressional Justification PDF version (209 KB) Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and title IV of the PHS Act with respect

NIH Websites Are Changing